The Nouveau Marché received a strong vote of confidence on Monday night when biotech company NicOx priced its €55m ($47m) follow-on offering at a slim discount to market price.

The deal, which is the first equity offering on the French high-growth exchange for nearly three months, was sold at €68.2, at a 1.7% discount to the closing price.